Fosaprepitant 115 mg, a lyophilized prodrug of aprepitant, may be substituted for oral EMEND (125 mg), 30 minutes prior to chemotherapy, on Day 1 only of the chemotherapy-induced nausea and vomiting (CINV) regimen as an intravenous infusion administered over 15 minutes.